Combined approach for the treatment of hypertension and dyslipidemia
EDITORIAL
- Combined approach for the treatment of hypertension and dyslipidemia: the case of the polypill
K. Teo, S. Yusuf, Canada
THEMED ARTICLES
-
- Why do we need a combined approach for the treatment of hypertension and dyslipidemia?
M. Burnier, Suisse - Hypertension and dyslipidemia: where are we?
- Latest developments in diagnosis and treatment according to recent hypertension guidelines
B. Williams , United Kingdom - Update on dyslipidemia diagnosis and treatment
U. Laufs , Germany
- Why do we need a combined approach for the treatment of hypertension and dyslipidemia?
CONTROVERSIAL QUESTION
-
-
- Challenge of medication nonadherence in daily practice
N. R. Rey , Philippines – J. Wolf, Poland – N. Zvartau, L. Korostovtseva, Russian Federation
- Challenge of medication nonadherence in daily practice
-
THERAPEUTIC OUTLOOK
-
- Clinical benefits of atorvastatin/perindopril (Euvascor) and atorvastatin/perindopril/amlodipine (Triveram)
C. Vlachopoulos, E. Solomou, Greece
- Clinical benefits of atorvastatin/perindopril (Euvascor) and atorvastatin/perindopril/amlodipine (Triveram)
Perspectives
-
- Perspectives of a combined approach for the treatment of hypertension and dyslipidemia
C. Borghi, M. Bove, Italy
- Perspectives of a combined approach for the treatment of hypertension and dyslipidemia